Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

Related Keywords

United States ,San Diego ,California ,Stelios Papadopoulos ,Prestons Klassen ,Preston Klassen ,Nasdaq ,Head Of Research ,Prnewswire Regulus Therapeutics Inc ,Rnas The Company Or Regulus ,Arena Pharmaceuticals ,Company Board Of Directors ,University Of Nebraska Medical Center ,Head Of Global Development At Orexigen Therapeutics ,Regulus Therapeutics Inc ,Head Of Research Development ,Amgen ,Regulus Therapeutics ,Executive Vice President ,Senior Vice President ,Global Development ,Executive Medical Director ,Therapeutics Area Head ,Nebraska Medical Center ,Health Sciences ,Duke University Medical ,Dominant Polycystic Kidney Disease ,